Experimental Basis of New Therapeutic Approaches to Septic Shock
In 1982, the distinguished scientist, David Tyrrell, wrote a monograph entitled “ The Abolition of Infection: Hope or Illusion?” . In it, he drew attention to the fact that the long-expected demise of infection as a “problem” was evidently not going to happen. Issues such as the development of antibiotic resistance in common bacteria, and the contribution of the host to the pathophysiological disease would, he said, require new and innovative approaches to the treatment of infection. The need for these new strategies was particularly apparent in the case of septic shock. Mortality was “stuck”, rising to 75% or more in established cases , and it was clear that this high mortality was not due simply to the inadequacy of antibiotics.
KeywordsToxicity Superoxide Glucocorticoid Peritonitis Staphylococcus
Unable to display preview. Download preview PDF.
- 1.Tyrrell DA (1982) The abolition of infection. Hope or illusion? Nuffield Provincial Hospitals Trust, London, pp 1–66Google Scholar
- 9.Appelmelk BJ, Verweij-Van Vught AM, Maaskant JJ, Schouten WF, Thijs LG, MacLaren DM ( 1986) Use of mucin and hemoglobin in experimental murine gram-negative bacteremia enhances the immunoprotective action of antibodies reactive with the lipopolysaccharide core region. Antonie van Leeuwenhoek 52:537–542PubMedCrossRefGoogle Scholar
- 26.Hinshaw LB, Emerson TE Jr, Taylor FB Jr, et al. (1992) Lethal Staphyococcus aureus-indu-ced shock in primates: Prevention of death with anti-TNF antibody. J Trauma (in press)Google Scholar
- 27.Wayte J, Silva AT, Cohen J (1991) Role of tumour necrosis factor (TNF) in experimental gram-positive sepsis. Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago. (Abst) 789Google Scholar
- 32.Wakabayashi G, Gelfand JA, Jung WK, Connolly RJ, Burke JF, Dinarello CA (1991) Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shockk-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli. J Clin Invest 87:1925–1935PubMedCrossRefGoogle Scholar
- 37.Exley AR, Buurman WA, Bodmer M, Cohen J (1989) Monoclonal antibody to recombinant human tumor necrosis factor in the prophylaxis and treatment of endotoxic shock in Cyno-molgus monkeys. Clin Sci 76:50pGoogle Scholar